These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 16300914

  • 1. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    Int J Pharm; 2006 Jan 13; 307(2):270-7. PubMed ID: 16300914
    [Abstract] [Full Text] [Related]

  • 2. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.
    Krauland AH, Leitner VM, Grabovac V, Bernkop-Schnürch A.
    J Pharm Sci; 2006 Nov 13; 95(11):2463-72. PubMed ID: 16886206
    [Abstract] [Full Text] [Related]

  • 3. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    J Control Release; 2004 Mar 24; 95(3):547-55. PubMed ID: 15023465
    [Abstract] [Full Text] [Related]

  • 4. Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system.
    Vetter A, Bernkop-Schnürch A.
    J Drug Target; 2010 May 24; 18(4):303-12. PubMed ID: 19947818
    [Abstract] [Full Text] [Related]

  • 5. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
    Wang J, Tabata Y, Morimoto K.
    J Control Release; 2006 Jun 12; 113(1):31-7. PubMed ID: 16707188
    [Abstract] [Full Text] [Related]

  • 6. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y, Wei W, Lv P, Wang L, Ma G.
    Eur J Pharm Biopharm; 2011 Jan 12; 77(1):11-9. PubMed ID: 20933083
    [Abstract] [Full Text] [Related]

  • 7. Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres.
    Pan Y, Zheng JM, Zhao HY, Li YJ, Xu H, Wei G.
    Acta Pharmacol Sin; 2002 Nov 12; 23(11):1051-6. PubMed ID: 12421485
    [Abstract] [Full Text] [Related]

  • 8. Preparation and in vitro evaluation of thiolated chitosan microparticles.
    Maculotti K, Genta I, Perugini P, Imam M, Bernkop-Schnürch A, Pavanetto F.
    J Microencapsul; 2005 Aug 12; 22(5):459-70. PubMed ID: 16361190
    [Abstract] [Full Text] [Related]

  • 9. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E, Rassu G, Sanna V, Cossu M, Giunchedi P.
    J Pharm Pharmacol; 2005 Mar 12; 57(3):287-94. PubMed ID: 15807983
    [Abstract] [Full Text] [Related]

  • 10. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
    Kafedjiiski K, Hoffer M, Werle M, Bernkop-Schnürch A.
    Biomaterials; 2006 Jan 12; 27(1):127-35. PubMed ID: 16045983
    [Abstract] [Full Text] [Related]

  • 11. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF, Hombach J, Bernkop-Schnürch A.
    Int J Pharm; 2008 Feb 04; 348(1-2):54-60. PubMed ID: 17716840
    [Abstract] [Full Text] [Related]

  • 12. Controlled drug delivery systems based on thiolated chitosan microspheres.
    Elhassan Imam M, Bernkop-Schnürch A.
    Drug Dev Ind Pharm; 2005 Jul 04; 31(6):557-65. PubMed ID: 16109629
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR, Sharma CP.
    J Control Release; 2009 Apr 17; 135(2):144-51. PubMed ID: 19331862
    [Abstract] [Full Text] [Related]

  • 14. The use of thiolated polymers as carrier matrix in oral peptide delivery--proof of concept.
    Bernkop-Schnürch A, Pinter Y, Guggi D, Kahlbacher H, Schöffmann G, Schuh M, Schmerold I, Del Curto MD, D'Antonio M, Esposito P, Huck C.
    J Control Release; 2005 Aug 18; 106(1-2):26-33. PubMed ID: 15939501
    [Abstract] [Full Text] [Related]

  • 15. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
    Föger F, Schmitz T, Bernkop-Schnürch A.
    Biomaterials; 2006 Aug 18; 27(23):4250-5. PubMed ID: 16618504
    [Abstract] [Full Text] [Related]

  • 16. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC, Chiang CH, Yeh MK.
    J Microencapsul; 2003 Aug 18; 20(2):247-60. PubMed ID: 12554378
    [Abstract] [Full Text] [Related]

  • 17. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U, Khar RK, Ahmed FJ, Panda AK.
    J Pharm Pharmacol; 2007 Oct 18; 59(10):1345-51. PubMed ID: 17910808
    [Abstract] [Full Text] [Related]

  • 18. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
    Wu ZH, Ping QN, Wei Y, Lai JM.
    Acta Pharmacol Sin; 2004 Jul 18; 25(7):966-72. PubMed ID: 15210073
    [Abstract] [Full Text] [Related]

  • 19. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G, Perera G, Vigl C, Pickl K, Sinner FM, Bernkop-Schnürch A.
    Drug Deliv; 2011 Apr 18; 18(3):190-7. PubMed ID: 21039318
    [Abstract] [Full Text] [Related]

  • 20. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G, Vetter A, Barthelmes J, Rahmat D, Laffleur F, Iqbal J, Perera G, Schlocker W, Dünnhaput S, Augustijns P, Bernkop-Schnürch A.
    Int J Pharm; 2012 May 30; 428(1-2):164-70. PubMed ID: 22421322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.